rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia (PMM2 Deficiency)

Background. Congenital disorders of glycosylation (CDG) are a group of rare disorders in which glycosylation required for proper protein-protein interactions and protein stability is disrupted, manifesting clinically with multiple system involvement and growth failure. The insulin-like growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Bradley S., Duffy, Meghann M., Addo, O. Yaw, Sarafoglou, Kyriakie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586814/
https://www.ncbi.nlm.nih.gov/pubmed/26425584
http://dx.doi.org/10.1177/2324709613503316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586814/
https://www.ncbi.nlm.nih.gov/pubmed/26425584
http://dx.doi.org/10.1177/2324709613503316

Ejemplares similares